Switzerland · Who invested in Vaderis Therapeutics?
Vaderis Therapeutics's investors include TCG Crossover, Life Sciences at Goldman Sachs Alternatives, Perceptive Advisors, TCG and Omega Funds, and 4 more on record. TCG Crossover led its latest round.
Switzerland · Series B startup
Who invested in Vaderis Therapeutics
One round we have observed, with the 9 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Vaderis Therapeutics and see its new rounds in your feed.Sign up free
Raised 3 months ago
Funding summaryUpdated 27 Oct 2026
$152Mraised across 1 round since 2026, from 4 sources
- Latest round
- Series B, $152MAug 2026
- Led by
- TCG Crossover and Life Sciences at Goldman Sachs Alternatives
- Investors
- 9 (2 led)
The rounds
- Aug 2026Series B$152M
TCG CrossoverLead- Life Sciences at Goldman Sachs AlternativesLead
Perceptive Advisors
TCG
Omega Funds
EQT Life Sciences
Medicxi
Droia Ventures- Kalehua Capital
Reported by Firms' own news pages and 3 others
Everyone who backed them
Life Sciences at Goldman Sachs AlternativesGrowth equity1round, led 1
Kalehua CapitalGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Vaderis Therapeutics
How much has Vaderis Therapeutics raised?
Vaderis Therapeutics has raised $152M across 1 round since 2026.
When did Vaderis Therapeutics last raise?
Vaderis Therapeutics's most recent round was a Series B of $152M in Aug 2026, led by TCG Crossover.
What was Vaderis Therapeutics's biggest round?
Its most recent round, $152M in Aug 2026, is also its largest on record.
Who backed Vaderis Therapeutics first?
Vaderis Therapeutics's first round on record, in Aug 2026, was backed by TCG Crossover, Life Sciences at Goldman Sachs Alternatives and Perceptive Advisors and 6 others.
What stage is Vaderis Therapeutics at?
Vaderis Therapeutics's latest named round is a Series B, in Aug 2026.
Where is Vaderis Therapeutics based?
Vaderis Therapeutics is based in Switzerland.
Who led Vaderis Therapeutics's rounds?
TCG Crossover led the Series B in 2026.
Companies like Vaderis Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.